These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women. Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S. J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648 [Abstract] [Full Text] [Related]
4. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ. Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358 [Abstract] [Full Text] [Related]
5. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines. Street ME, Spaggiari C, Ziveri MA, Volta C, Federico G, Baroncelli GI, Bernasconi S, Saggese G. Horm Res; 2006 Mar; 66(4):162-8. PubMed ID: 16804317 [Abstract] [Full Text] [Related]
6. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy. Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S. J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754 [Abstract] [Full Text] [Related]
7. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent. Malpe R, Baylink DJ, Linkhart TA, Wergedal JE, Mohan S. J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585 [Abstract] [Full Text] [Related]
9. Insulin-like growth factor binding proteins 4 and 5 and bone mineral density in elderly men and women. Karasik D, Rosen CJ, Hannan MT, Broe KE, Dawson-Hughes B, Gagnon DR, Wilson PW, Visser M, Langlois JA, Mohan S, Kiel DP. Calcif Tissue Int; 2002 Oct; 71(4):323-8. PubMed ID: 12202958 [Abstract] [Full Text] [Related]
12. Age-related serum levels of insulin-like growth factor-I, -II and IGF-binding protein-3 following myocardial infarction. Reeves I, Abribat T, Laramee P, Jasmin G, Brazeau P. Growth Horm IGF Res; 2000 Apr; 10(2):78-84. PubMed ID: 10931745 [Abstract] [Full Text] [Related]
13. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability. Lindgren BF, Segovia B, Lassarre C, Binoux M, Gourmelen M. Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649 [Abstract] [Full Text] [Related]
14. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. Grønbaek H, Flyvbjerg A, Mellemkjaer L, Tjønneland A, Christensen J, Sørensen HT, Overvad K. Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1759-64. PubMed ID: 15533904 [Abstract] [Full Text] [Related]
16. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands. Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH. Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992 [Abstract] [Full Text] [Related]
17. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants. Akcakus M, Koklu E, Kurtoglu S, Kula M, Koklu SS. Am J Perinatol; 2006 Nov; 23(8):473-80. PubMed ID: 17094045 [Abstract] [Full Text] [Related]
18. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60. Kim JG, Shin CS, Choi YM, Moon SY, Kim SY, Lee JY. Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009 [Abstract] [Full Text] [Related]